Disease severity affects the long-term visual outcome of Peter's anomaly.
EMA grants positive CHMP opinion for low-dose atropine SYD-101 (Ryjunea, Sydnexis)
A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary endpoint for slowing paediatric myopia progression
Higher Molar Dose and Its Translation into Clinical Practice
Up for debate: Clinicians take on hot topics at the Congress on Controversies in Ophthalmology
This year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain
International study illuminates economic burden of late-stage age-related macular degeneration
Researchers assessed the costs to patients and caregivers in Germany, Bulgaria and the US
Accommodative intraocular lenses: Are they coming back?
A resurgence in this IOL technology could create new possibilities in refractive correction
Paediatric myopia study indicates lens thickness and power changes closely associated with age
The study assessed a large paediatric cohort for changes in spherical equivalent refraction, axial length, lens power and lens thickness
